5.6% Stake of Teladoc Inc (TDOC) Owned by Trident Capital Management-Vi, L.L.C.

Trident Capital Management-Vi, L.L.C.

recently stated that they own 5.6% of Teladoc Inc (NYSE:TDOC) in a Form 13G/A disclosure that was filed with the SEC on Wednesday, February 7th. The investor owns 3,392,226 shares of the stock valued at $117,710,242. The reporting parties listed on the disclosure included Trident Capital ManagementVI, LLC, Trident Capital FundVI, LP and Trident Capital FundVI Principals Fund, LLC. The disclosure is available through the SEC website at this hyperlink.

Trident Capital Management-Vi, L.L.C.

provided the following explanation of their ownership:

A number of other institutional investors and hedge funds have also modified their holdings of the business. Raymond James Trust N.A. raised its holdings in Teladoc by 36.2% in the 3rd quarter. Raymond James Trust N.A. now owns 9,943 shares of the health services provider’s stock valued at $330,000 after acquiring an additional 2,643 shares during the last quarter. American International Group Inc. grew its stake in shares of Teladoc by 8.1% during the 3rd quarter. American International Group Inc. now owns 36,079 shares of the health services provider’s stock valued at $1,196,000 after buying an additional 2,697 shares during the period. Ameritas Investment Partners Inc. grew its stake in shares of Teladoc by 134.2% during the 2nd quarter. Ameritas Investment Partners Inc. now owns 4,724 shares of the health services provider’s stock valued at $164,000 after buying an additional 2,707 shares during the period. Emerald Advisers Inc. PA grew its stake in shares of Teladoc by 0.5% during the 4th quarter. Emerald Advisers Inc. PA now owns 566,096 shares of the health services provider’s stock valued at $19,728,000 after buying an additional 2,784 shares during the period. Finally, SG Americas Securities LLC purchased a new stake in shares of Teladoc during the 4th quarter valued at $101,000.

In related news, CEO Jason N. Gorevic sold 100,000 shares of the company’s stock in a transaction on Monday, December 4th. The shares were sold at an average price of $32.99, for a total transaction of $3,299,000.00. Following the completion of the sale, the chief executive officer now directly owns 718,261 shares of the company’s stock, valued at approximately $23,695,430.39. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CFO Mark Hirschhorn sold 30,000 shares of the company’s stock in a transaction on Monday, December 4th. The stock was sold at an average price of $32.99, for a total transaction of $989,700.00. Following the sale, the chief financial officer now directly owns 5,203 shares of the company’s stock, valued at $171,646.97. The disclosure for this sale can be found here. 4.47% of the stock is currently owned by corporate insiders.

Shares of Teladoc Inc (NYSE:TDOC) opened at $34.70 on Wednesday. The company has a debt-to-equity ratio of 0.83, a current ratio of 5.08 and a quick ratio of 5.08. Teladoc Inc has a 12-month low of $19.60 and a 12-month high of $38.40.

Several analysts have recently issued reports on TDOC shares. Oppenheimer boosted their price objective on shares of Teladoc from $40.00 to $45.00 and gave the company an “outperform” rating in a research note on Tuesday, November 21st. Zacks Investment Research cut shares of Teladoc from a “buy” rating to a “hold” rating in a research note on Wednesday, October 18th. KeyCorp reissued a “buy” rating and set a $41.00 price objective on shares of Teladoc in a research note on Wednesday, January 10th. Citigroup started coverage on shares of Teladoc in a research note on Thursday, January 4th. They set a “buy” rating for the company. Finally, Deutsche Bank started coverage on shares of Teladoc in a research note on Friday, December 8th. They set a “buy” rating and a $39.00 price objective for the company. One investment analyst has rated the stock with a sell rating, five have given a hold rating and twelve have assigned a buy rating to the company. The stock presently has a consensus rating of “Buy” and an average price target of $39.43.

WARNING: This piece was posted by Community Financial News and is the property of of Community Financial News. If you are accessing this piece on another website, it was illegally stolen and reposted in violation of United States & international trademark & copyright law. The legal version of this piece can be accessed at https://www.com-unik.info/2018/02/07/5-6-stake-of-teladoc-inc-tdoc-owned-by-trident-capital-management-vi-l-l-c.html.

About Teladoc

Teladoc, Inc is a telehealth company. The Company offers telehealth platform, delivering on-demand healthcare anytime, anywhere, through mobile devices, the Internet, video and phone. The Company’s solution connects its Members, with its over 3,000 board certified physicians and behavioral health professionals treating a range of conditions and cases from acute diagnoses, such as upper respiratory infection, urinary tract infection and sinusitis to dermatological conditions, anxiety and smoking cessation.

Institutional Ownership by Quarter for Teladoc (NYSE:TDOC)

Receive News & Ratings for Teladoc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit